nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—Hypokalaemia—Vismodegib—skin cancer	0.0134	0.0136	CcSEcCtD
Sodium stibogluconate—Tingling sensation—Imiquimod—skin cancer	0.0132	0.0135	CcSEcCtD
Sodium stibogluconate—Tenderness—Imiquimod—skin cancer	0.0122	0.0125	CcSEcCtD
Sodium stibogluconate—Ulcer—Imiquimod—skin cancer	0.0113	0.0115	CcSEcCtD
Sodium stibogluconate—Coagulopathy—Dactinomycin—skin cancer	0.00906	0.00925	CcSEcCtD
Sodium stibogluconate—Lung disorder—Temozolomide—skin cancer	0.00902	0.0092	CcSEcCtD
Sodium stibogluconate—Necrosis—Dactinomycin—skin cancer	0.00899	0.00918	CcSEcCtD
Sodium stibogluconate—TOP1—hair follicle—skin cancer	0.00896	0.44	CbGeAlD
Sodium stibogluconate—Swelling—Imiquimod—skin cancer	0.00876	0.00894	CcSEcCtD
Sodium stibogluconate—Tenderness—Bleomycin—skin cancer	0.00867	0.00885	CcSEcCtD
Sodium stibogluconate—Extravasation—Bleomycin—skin cancer	0.00867	0.00885	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Vismodegib—skin cancer	0.00865	0.00883	CcSEcCtD
Sodium stibogluconate—Coagulopathy—Temozolomide—skin cancer	0.0082	0.00837	CcSEcCtD
Sodium stibogluconate—Extravasation—Dactinomycin—skin cancer	0.00809	0.00826	CcSEcCtD
Sodium stibogluconate—Ulcer—Bleomycin—skin cancer	0.008	0.00816	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Imiquimod—skin cancer	0.00789	0.00805	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Dactinomycin—skin cancer	0.00771	0.00787	CcSEcCtD
Sodium stibogluconate—Necrosis—Fluorouracil—skin cancer	0.00749	0.00765	CcSEcCtD
Sodium stibogluconate—Ulcer—Dactinomycin—skin cancer	0.00746	0.00761	CcSEcCtD
Sodium stibogluconate—Irritability—Imiquimod—skin cancer	0.00738	0.00753	CcSEcCtD
Sodium stibogluconate—Tingling sensation—Fluorouracil—skin cancer	0.00731	0.00747	CcSEcCtD
Sodium stibogluconate—Tenderness—Fluorouracil—skin cancer	0.00674	0.00688	CcSEcCtD
Sodium stibogluconate—Extravasation—Fluorouracil—skin cancer	0.00674	0.00688	CcSEcCtD
Sodium stibogluconate—Sweating increased—Imiquimod—skin cancer	0.00651	0.00664	CcSEcCtD
Sodium stibogluconate—Cellulitis—Fluorouracil—skin cancer	0.00647	0.0066	CcSEcCtD
Sodium stibogluconate—Bronchitis—Imiquimod—skin cancer	0.00643	0.00656	CcSEcCtD
Sodium stibogluconate—Phlebitis—Bleomycin—skin cancer	0.00637	0.00651	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Vismodegib—skin cancer	0.00627	0.0064	CcSEcCtD
Sodium stibogluconate—Intestinal obstruction—Docetaxel—skin cancer	0.00623	0.00636	CcSEcCtD
Sodium stibogluconate—Fatigue—Vismodegib—skin cancer	0.00622	0.00635	CcSEcCtD
Sodium stibogluconate—Ulcer—Fluorouracil—skin cancer	0.00622	0.00635	CcSEcCtD
Sodium stibogluconate—Constipation—Vismodegib—skin cancer	0.00617	0.00629	CcSEcCtD
Sodium stibogluconate—Disorientation—Bleomycin—skin cancer	0.00614	0.00627	CcSEcCtD
Sodium stibogluconate—Sepsis—Dactinomycin—skin cancer	0.00612	0.00625	CcSEcCtD
Sodium stibogluconate—TOP1—nipple—skin cancer	0.00608	0.298	CbGeAlD
Sodium stibogluconate—Phlebitis—Dactinomycin—skin cancer	0.00595	0.00607	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Vismodegib—skin cancer	0.0059	0.00602	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Imiquimod—skin cancer	0.00587	0.00599	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Imiquimod—skin cancer	0.00584	0.00596	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Vismodegib—skin cancer	0.0057	0.00582	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Bleomycin—skin cancer	0.0056	0.00572	CcSEcCtD
Sodium stibogluconate—Necrosis—Docetaxel—skin cancer	0.00541	0.00552	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Vemurafenib—skin cancer	0.00535	0.00546	CcSEcCtD
Sodium stibogluconate—Asthenia—Vismodegib—skin cancer	0.00517	0.00528	CcSEcCtD
Sodium stibogluconate—Sepsis—Fluorouracil—skin cancer	0.0051	0.00521	CcSEcCtD
Sodium stibogluconate—Pruritus—Vismodegib—skin cancer	0.0051	0.00521	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Vismodegib—skin cancer	0.00493	0.00504	CcSEcCtD
Sodium stibogluconate—Extravasation—Docetaxel—skin cancer	0.00486	0.00497	CcSEcCtD
Sodium stibogluconate—Swelling—Fluorouracil—skin cancer	0.00484	0.00494	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Imiquimod—skin cancer	0.00478	0.00488	CcSEcCtD
Sodium stibogluconate—Disorientation—Fluorouracil—skin cancer	0.00477	0.00487	CcSEcCtD
Sodium stibogluconate—Bronchospasm—Bleomycin—skin cancer	0.00467	0.00477	CcSEcCtD
Sodium stibogluconate—Oliguria—Docetaxel—skin cancer	0.00461	0.0047	CcSEcCtD
Sodium stibogluconate—Vomiting—Vismodegib—skin cancer	0.00458	0.00468	CcSEcCtD
Sodium stibogluconate—Rash—Vismodegib—skin cancer	0.00455	0.00464	CcSEcCtD
Sodium stibogluconate—Dermatitis—Vismodegib—skin cancer	0.00454	0.00464	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Vemurafenib—skin cancer	0.00446	0.00455	CcSEcCtD
Sodium stibogluconate—Dysphagia—Dactinomycin—skin cancer	0.00443	0.00452	CcSEcCtD
Sodium stibogluconate—Infection—Vemurafenib—skin cancer	0.00443	0.00452	CcSEcCtD
Sodium stibogluconate—Dehydration—Temozolomide—skin cancer	0.00431	0.0044	CcSEcCtD
Sodium stibogluconate—Nausea—Vismodegib—skin cancer	0.00428	0.00437	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Temozolomide—skin cancer	0.00422	0.0043	CcSEcCtD
Sodium stibogluconate—Syncope—Imiquimod—skin cancer	0.00417	0.00426	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Bleomycin—skin cancer	0.00417	0.00426	CcSEcCtD
Sodium stibogluconate—Hypotension—Vemurafenib—skin cancer	0.00416	0.00425	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Bleomycin—skin cancer	0.00415	0.00423	CcSEcCtD
Sodium stibogluconate—Palpitations—Imiquimod—skin cancer	0.00411	0.0042	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Imiquimod—skin cancer	0.00409	0.00418	CcSEcCtD
Sodium stibogluconate—Irritability—Fluorouracil—skin cancer	0.00407	0.00416	CcSEcCtD
Sodium stibogluconate—Convulsion—Imiquimod—skin cancer	0.00403	0.00412	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Temozolomide—skin cancer	0.00403	0.00411	CcSEcCtD
Sodium stibogluconate—Fluid retention—Docetaxel—skin cancer	0.00403	0.00411	CcSEcCtD
Sodium stibogluconate—Dysphagia—Temozolomide—skin cancer	0.004	0.00409	CcSEcCtD
Sodium stibogluconate—Chest pain—Imiquimod—skin cancer	0.00396	0.00405	CcSEcCtD
Sodium stibogluconate—Anxiety—Imiquimod—skin cancer	0.00395	0.00403	CcSEcCtD
Sodium stibogluconate—Sweating increased—Temozolomide—skin cancer	0.0039	0.00398	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Vemurafenib—skin cancer	0.00387	0.00395	CcSEcCtD
Sodium stibogluconate—Bronchitis—Temozolomide—skin cancer	0.00385	0.00393	CcSEcCtD
Sodium stibogluconate—Fatigue—Vemurafenib—skin cancer	0.00384	0.00392	CcSEcCtD
Sodium stibogluconate—Constipation—Vemurafenib—skin cancer	0.00381	0.00389	CcSEcCtD
Sodium stibogluconate—Oedema—Imiquimod—skin cancer	0.0038	0.00388	CcSEcCtD
Sodium stibogluconate—Lightheadedness—Docetaxel—skin cancer	0.0038	0.00388	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Bleomycin—skin cancer	0.00378	0.00386	CcSEcCtD
Sodium stibogluconate—Infection—Imiquimod—skin cancer	0.00377	0.00385	CcSEcCtD
Sodium stibogluconate—Shock—Imiquimod—skin cancer	0.00374	0.00382	CcSEcCtD
Sodium stibogluconate—Tachycardia—Imiquimod—skin cancer	0.00371	0.00379	CcSEcCtD
Sodium stibogluconate—Dysphagia—Fluorouracil—skin cancer	0.00369	0.00377	CcSEcCtD
Sodium stibogluconate—Sepsis—Docetaxel—skin cancer	0.00368	0.00376	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Imiquimod—skin cancer	0.00367	0.00375	CcSEcCtD
Sodium stibogluconate—Anorexia—Imiquimod—skin cancer	0.00362	0.0037	CcSEcCtD
Sodium stibogluconate—Phlebitis—Docetaxel—skin cancer	0.00358	0.00365	CcSEcCtD
Sodium stibogluconate—TOP1—mammalian vulva—skin cancer	0.00355	0.174	CbGeAlD
Sodium stibogluconate—Body temperature increased—Vemurafenib—skin cancer	0.00352	0.0036	CcSEcCtD
Sodium stibogluconate—Swelling—Docetaxel—skin cancer	0.00349	0.00356	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Imiquimod—skin cancer	0.00341	0.00348	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Docetaxel—skin cancer	0.0034	0.00347	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Imiquimod—skin cancer	0.00339	0.00346	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Imiquimod—skin cancer	0.0033	0.00337	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Vemurafenib—skin cancer	0.00328	0.00335	CcSEcCtD
Sodium stibogluconate—Fatigue—Imiquimod—skin cancer	0.00328	0.00334	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Fluorouracil—skin cancer	0.00324	0.00331	CcSEcCtD
Sodium stibogluconate—Renal impairment—Docetaxel—skin cancer	0.00324	0.0033	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Fluorouracil—skin cancer	0.00322	0.00329	CcSEcCtD
Sodium stibogluconate—Asthenia—Vemurafenib—skin cancer	0.0032	0.00326	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Temozolomide—skin cancer	0.00319	0.00325	CcSEcCtD
Sodium stibogluconate—Pruritus—Vemurafenib—skin cancer	0.00315	0.00322	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Imiquimod—skin cancer	0.00311	0.00317	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Docetaxel—skin cancer	0.00309	0.00316	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Vemurafenib—skin cancer	0.00305	0.00311	CcSEcCtD
Sodium stibogluconate—Urticaria—Imiquimod—skin cancer	0.00302	0.00308	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Imiquimod—skin cancer	0.003	0.00307	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Imiquimod—skin cancer	0.003	0.00307	CcSEcCtD
Sodium stibogluconate—Dizziness—Vemurafenib—skin cancer	0.00295	0.00301	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Fluorouracil—skin cancer	0.00294	0.003	CcSEcCtD
Sodium stibogluconate—Dehydration—Docetaxel—skin cancer	0.00286	0.00292	CcSEcCtD
Sodium stibogluconate—Vomiting—Vemurafenib—skin cancer	0.00283	0.00289	CcSEcCtD
Sodium stibogluconate—Chest pain—Bleomycin—skin cancer	0.00282	0.00287	CcSEcCtD
Sodium stibogluconate—Rash—Vemurafenib—skin cancer	0.00281	0.00287	CcSEcCtD
Sodium stibogluconate—Dermatitis—Vemurafenib—skin cancer	0.00281	0.00286	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Imiquimod—skin cancer	0.0028	0.00286	CcSEcCtD
Sodium stibogluconate—Headache—Vemurafenib—skin cancer	0.00279	0.00285	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Temozolomide—skin cancer	0.00273	0.00279	CcSEcCtD
Sodium stibogluconate—Asthenia—Imiquimod—skin cancer	0.00273	0.00278	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Bleomycin—skin cancer	0.0027	0.00276	CcSEcCtD
Sodium stibogluconate—Oedema—Bleomycin—skin cancer	0.0027	0.00276	CcSEcCtD
Sodium stibogluconate—Pruritus—Imiquimod—skin cancer	0.00269	0.00274	CcSEcCtD
Sodium stibogluconate—Infection—Bleomycin—skin cancer	0.00268	0.00274	CcSEcCtD
Sodium stibogluconate—Dysphagia—Docetaxel—skin cancer	0.00266	0.00272	CcSEcCtD
Sodium stibogluconate—Nausea—Vemurafenib—skin cancer	0.00265	0.0027	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Fluorouracil—skin cancer	0.00264	0.00269	CcSEcCtD
Sodium stibogluconate—Vision blurred—Temozolomide—skin cancer	0.00263	0.00268	CcSEcCtD
Sodium stibogluconate—Bronchospasm—Docetaxel—skin cancer	0.00262	0.00267	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Imiquimod—skin cancer	0.0026	0.00265	CcSEcCtD
Sodium stibogluconate—Anorexia—Bleomycin—skin cancer	0.00257	0.00263	CcSEcCtD
Sodium stibogluconate—Hypotension—Bleomycin—skin cancer	0.00252	0.00257	CcSEcCtD
Sodium stibogluconate—Oedema—Dactinomycin—skin cancer	0.00252	0.00257	CcSEcCtD
Sodium stibogluconate—Dizziness—Imiquimod—skin cancer	0.00251	0.00256	CcSEcCtD
Sodium stibogluconate—Infection—Dactinomycin—skin cancer	0.0025	0.00255	CcSEcCtD
Sodium stibogluconate—Palpitations—Temozolomide—skin cancer	0.00247	0.00252	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Bleomycin—skin cancer	0.00242	0.00247	CcSEcCtD
Sodium stibogluconate—Vision blurred—Fluorouracil—skin cancer	0.00242	0.00247	CcSEcCtD
Sodium stibogluconate—Convulsion—Temozolomide—skin cancer	0.00242	0.00247	CcSEcCtD
Sodium stibogluconate—Vomiting—Imiquimod—skin cancer	0.00242	0.00247	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Bleomycin—skin cancer	0.00241	0.00246	CcSEcCtD
Sodium stibogluconate—Anorexia—Dactinomycin—skin cancer	0.0024	0.00245	CcSEcCtD
Sodium stibogluconate—Rash—Imiquimod—skin cancer	0.0024	0.00245	CcSEcCtD
Sodium stibogluconate—Dermatitis—Imiquimod—skin cancer	0.00239	0.00244	CcSEcCtD
Sodium stibogluconate—Headache—Imiquimod—skin cancer	0.00238	0.00243	CcSEcCtD
Sodium stibogluconate—Anxiety—Temozolomide—skin cancer	0.00237	0.00242	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Bleomycin—skin cancer	0.00235	0.0024	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Docetaxel—skin cancer	0.00234	0.00239	CcSEcCtD
Sodium stibogluconate—Renal failure—Docetaxel—skin cancer	0.00233	0.00238	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Docetaxel—skin cancer	0.00233	0.00238	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Temozolomide—skin cancer	0.00228	0.00232	CcSEcCtD
Sodium stibogluconate—Oedema—Temozolomide—skin cancer	0.00228	0.00232	CcSEcCtD
Sodium stibogluconate—Infection—Temozolomide—skin cancer	0.00226	0.00231	CcSEcCtD
Sodium stibogluconate—Nausea—Imiquimod—skin cancer	0.00226	0.0023	CcSEcCtD
Sodium stibogluconate—Convulsion—Fluorouracil—skin cancer	0.00223	0.00227	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Temozolomide—skin cancer	0.0022	0.00225	CcSEcCtD
Sodium stibogluconate—Chest pain—Fluorouracil—skin cancer	0.00219	0.00223	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Dactinomycin—skin cancer	0.00219	0.00223	CcSEcCtD
Sodium stibogluconate—Fatigue—Dactinomycin—skin cancer	0.00217	0.00222	CcSEcCtD
Sodium stibogluconate—Anorexia—Temozolomide—skin cancer	0.00217	0.00222	CcSEcCtD
Sodium stibogluconate—Urticaria—Bleomycin—skin cancer	0.00214	0.00219	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Bleomycin—skin cancer	0.00213	0.00218	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Docetaxel—skin cancer	0.00212	0.00216	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Fluorouracil—skin cancer	0.0021	0.00214	CcSEcCtD
Sodium stibogluconate—Oedema—Fluorouracil—skin cancer	0.0021	0.00214	CcSEcCtD
Sodium stibogluconate—Infection—Fluorouracil—skin cancer	0.00208	0.00213	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Dactinomycin—skin cancer	0.00206	0.0021	CcSEcCtD
Sodium stibogluconate—Tachycardia—Fluorouracil—skin cancer	0.00205	0.00209	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Temozolomide—skin cancer	0.00204	0.00209	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Temozolomide—skin cancer	0.00203	0.00207	CcSEcCtD
Sodium stibogluconate—Anorexia—Fluorouracil—skin cancer	0.002	0.00204	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Dactinomycin—skin cancer	0.00199	0.00203	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Dactinomycin—skin cancer	0.00199	0.00203	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Bleomycin—skin cancer	0.00199	0.00203	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Temozolomide—skin cancer	0.00198	0.00202	CcSEcCtD
Sodium stibogluconate—Fatigue—Temozolomide—skin cancer	0.00196	0.002	CcSEcCtD
Sodium stibogluconate—Hypotension—Fluorouracil—skin cancer	0.00196	0.002	CcSEcCtD
Sodium stibogluconate—Constipation—Temozolomide—skin cancer	0.00195	0.00199	CcSEcCtD
Sodium stibogluconate—Asthenia—Bleomycin—skin cancer	0.00194	0.00198	CcSEcCtD
Sodium stibogluconate—Pruritus—Bleomycin—skin cancer	0.00191	0.00195	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Docetaxel—skin cancer	0.0019	0.00194	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Fluorouracil—skin cancer	0.00188	0.00192	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Fluorouracil—skin cancer	0.00187	0.00191	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Temozolomide—skin cancer	0.00186	0.0019	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Dactinomycin—skin cancer	0.00185	0.00189	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Fluorouracil—skin cancer	0.00182	0.00186	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Docetaxel—skin cancer	0.00182	0.00185	CcSEcCtD
Sodium stibogluconate—Urticaria—Temozolomide—skin cancer	0.00181	0.00185	CcSEcCtD
Sodium stibogluconate—Asthenia—Dactinomycin—skin cancer	0.00181	0.00184	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Temozolomide—skin cancer	0.0018	0.00184	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Temozolomide—skin cancer	0.0018	0.00184	CcSEcCtD
Sodium stibogluconate—TOP1—lymph node—skin cancer	0.00178	0.0873	CbGeAlD
Sodium stibogluconate—Diarrhoea—Dactinomycin—skin cancer	0.00172	0.00176	CcSEcCtD
Sodium stibogluconate—Vomiting—Bleomycin—skin cancer	0.00172	0.00175	CcSEcCtD
Sodium stibogluconate—Rash—Bleomycin—skin cancer	0.0017	0.00174	CcSEcCtD
Sodium stibogluconate—Dermatitis—Bleomycin—skin cancer	0.0017	0.00174	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Temozolomide—skin cancer	0.00168	0.00171	CcSEcCtD
Sodium stibogluconate—Urticaria—Fluorouracil—skin cancer	0.00167	0.0017	CcSEcCtD
Sodium stibogluconate—Syncope—Docetaxel—skin cancer	0.00166	0.0017	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Fluorouracil—skin cancer	0.00166	0.00169	CcSEcCtD
Sodium stibogluconate—Palpitations—Docetaxel—skin cancer	0.00164	0.00167	CcSEcCtD
Sodium stibogluconate—Asthenia—Temozolomide—skin cancer	0.00163	0.00167	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Docetaxel—skin cancer	0.00163	0.00166	CcSEcCtD
Sodium stibogluconate—Pruritus—Temozolomide—skin cancer	0.00161	0.00164	CcSEcCtD
Sodium stibogluconate—Convulsion—Docetaxel—skin cancer	0.00161	0.00164	CcSEcCtD
Sodium stibogluconate—Nausea—Bleomycin—skin cancer	0.0016	0.00164	CcSEcCtD
Sodium stibogluconate—Vomiting—Dactinomycin—skin cancer	0.0016	0.00163	CcSEcCtD
Sodium stibogluconate—Rash—Dactinomycin—skin cancer	0.00159	0.00162	CcSEcCtD
Sodium stibogluconate—Chest pain—Docetaxel—skin cancer	0.00158	0.00161	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Temozolomide—skin cancer	0.00156	0.00159	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Fluorouracil—skin cancer	0.00155	0.00158	CcSEcCtD
Sodium stibogluconate—Oedema—Docetaxel—skin cancer	0.00151	0.00155	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Docetaxel—skin cancer	0.00151	0.00155	CcSEcCtD
Sodium stibogluconate—Dizziness—Temozolomide—skin cancer	0.00151	0.00154	CcSEcCtD
Sodium stibogluconate—Infection—Docetaxel—skin cancer	0.0015	0.00154	CcSEcCtD
Sodium stibogluconate—Nausea—Dactinomycin—skin cancer	0.0015	0.00153	CcSEcCtD
Sodium stibogluconate—Shock—Docetaxel—skin cancer	0.00149	0.00152	CcSEcCtD
Sodium stibogluconate—Pruritus—Fluorouracil—skin cancer	0.00148	0.00152	CcSEcCtD
Sodium stibogluconate—Tachycardia—Docetaxel—skin cancer	0.00148	0.00151	CcSEcCtD
Sodium stibogluconate—Vomiting—Temozolomide—skin cancer	0.00145	0.00148	CcSEcCtD
Sodium stibogluconate—Anorexia—Docetaxel—skin cancer	0.00144	0.00147	CcSEcCtD
Sodium stibogluconate—Rash—Temozolomide—skin cancer	0.00144	0.00147	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Fluorouracil—skin cancer	0.00144	0.00147	CcSEcCtD
Sodium stibogluconate—Dermatitis—Temozolomide—skin cancer	0.00143	0.00146	CcSEcCtD
Sodium stibogluconate—Headache—Temozolomide—skin cancer	0.00143	0.00146	CcSEcCtD
Sodium stibogluconate—Hypotension—Docetaxel—skin cancer	0.00141	0.00144	CcSEcCtD
Sodium stibogluconate—Dizziness—Fluorouracil—skin cancer	0.00139	0.00142	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Docetaxel—skin cancer	0.00136	0.00139	CcSEcCtD
Sodium stibogluconate—Nausea—Temozolomide—skin cancer	0.00135	0.00138	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Docetaxel—skin cancer	0.00135	0.00138	CcSEcCtD
Sodium stibogluconate—Vomiting—Fluorouracil—skin cancer	0.00133	0.00136	CcSEcCtD
Sodium stibogluconate—Rash—Fluorouracil—skin cancer	0.00132	0.00135	CcSEcCtD
Sodium stibogluconate—Dermatitis—Fluorouracil—skin cancer	0.00132	0.00135	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Docetaxel—skin cancer	0.00132	0.00134	CcSEcCtD
Sodium stibogluconate—Headache—Fluorouracil—skin cancer	0.00131	0.00134	CcSEcCtD
Sodium stibogluconate—Fatigue—Docetaxel—skin cancer	0.00131	0.00133	CcSEcCtD
Sodium stibogluconate—Constipation—Docetaxel—skin cancer	0.00129	0.00132	CcSEcCtD
Sodium stibogluconate—Nausea—Fluorouracil—skin cancer	0.00125	0.00127	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Docetaxel—skin cancer	0.00124	0.00126	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Docetaxel—skin cancer	0.0012	0.00122	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Docetaxel—skin cancer	0.0012	0.00122	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Docetaxel—skin cancer	0.00112	0.00114	CcSEcCtD
Sodium stibogluconate—Asthenia—Docetaxel—skin cancer	0.00109	0.00111	CcSEcCtD
Sodium stibogluconate—Pruritus—Docetaxel—skin cancer	0.00107	0.00109	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Docetaxel—skin cancer	0.00104	0.00106	CcSEcCtD
Sodium stibogluconate—Dizziness—Docetaxel—skin cancer	0.001	0.00102	CcSEcCtD
Sodium stibogluconate—Vomiting—Docetaxel—skin cancer	0.000963	0.000983	CcSEcCtD
Sodium stibogluconate—Rash—Docetaxel—skin cancer	0.000955	0.000975	CcSEcCtD
Sodium stibogluconate—Dermatitis—Docetaxel—skin cancer	0.000954	0.000974	CcSEcCtD
Sodium stibogluconate—Headache—Docetaxel—skin cancer	0.000949	0.000968	CcSEcCtD
Sodium stibogluconate—Nausea—Docetaxel—skin cancer	0.000899	0.000918	CcSEcCtD
